Answers are grounded in this paper and cite their sources.
In this article, we consider four aspects of the regulatory standing of status epilepticus and the difficulties these raise in relation to trials and licensing. These formed the basis of a discussion held at the 6th London?Innsbruck Colloquium on Status Epilepticus, held on April 6, 2017.
No takes yet. Share an insight, caveat, or question.
Shorvon et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: